A carregar...
Beneficial effects of glatiramer acetate in Huntington’s disease mouse models: evidence for BDNF-elevating and immunomodulatory mechanisms
Huntington’s disease (HD) is a fatal, neurodegenerative movement disorder that has no cure and few treatment options. In these preclinical studies, we tested the effects of chronic treatment of glatiramer acetate (GA; Copaxone®), an FDA-approved drug used as first-line therapy for MS, in two differe...
Na minha lista:
| Publicado no: | Brain Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5595665/ https://ncbi.nlm.nih.gov/pubmed/28823953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.brainres.2017.08.013 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|